Report ID: SQMIG35H2067
Recombinant DNA Technology Market Size, Share, Growth Analysis, By Product(Medical (Therapeutic Agent, Human Protein, Vaccines), Non-Medical (Biotech Crops), By Component(Expression System (Mammalian, Bacteria, Yeast, Baculovirus/Insect)), By Application(Health and disease (Human, Animal), Food and Agriculture, Environment), By End User(Pharmaceutical and biotechnology companies, Research institutes, Others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2067 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|
Tables:
124 |
Figures:
77
Recombinant DNA Technology Market Regional Insights
North America dominated the global market. The largest portion of the North American continent can be ascribed to the country's high concentration of biopharmaceutical manufacturing companies. Development aid has also been aided by the existence of powerful regulatory bodies that can keep an eye on the numerous ethical and scientific issues raised by the use of technology.
The availability of cost-effective manufacturing facilities in Asian countries such as China have attracted the attention of multinational corporations planning to shift their operations to this region. On a per capita basis, Japan is also one of the leading importers of food and feed made with modern biotechnology. In Japan, the GE agriculture regulatory framework is becoming more effective. In addition, there are no significant trade restrictions in place in Japan that would obstruct the export of GE items from Western countries. As a result, during the forecast period, Asia-Pacific is expected to have the fastest market growth in the region.
Recombinant DNA Technology Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
